Pertussis, or whooping cough, is a highly contagious bacterial infection caused by Bordetella pertussis that attacks the respiratory tract. It begins with cold-like symptoms but progresses to severe coughing fits that can last for weeks and may cause a high-pitched "whoop" sound during inhalation.
The disease has three distinct phases: catarrhal, paroxysmal, and convalescent. During the catarrhal phase, lasting 1-2 weeks, symptoms resemble a common cold-runny nose, low-grade fever, mild cough. This stage is often misdiagnosed because it lacks distinctive features. The paroxysmal phase follows, marked by intense coughing episodes that occur in rapid bursts, sometimes ending in vomiting or exhaustion. The convalescent phase lasts several weeks and involves gradual recovery, though coughing may persist.
Children under 1 year are most vulnerable. According to the CDC, infants younger than 6 months have the highest risk of hospitalization and death from pertussis. Unvaccinated individuals remain at significant risk throughout life. The bacteria spread through respiratory droplets, making close contact in households or schools a common transmission route.
The progression of pertussis is predictable but often overlooked due to its initial similarity to viral upper respiratory infections. In the catarrhal phase, symptoms include sneezing, nasal congestion, and a mild persistent cough. These signs typically last 1-2 weeks and are easily mistaken for a standard cold. During this time, the infected person is highly contagious, even before the sign cough appears.
After 1-2 weeks, the paroxysmal phase begins. Coughing episodes become violent and uncontrollable, occurring in clusters throughout the day and night. A child may cough 10-20 times in succession, followed by a gasping breath that produces the characteristic "whoop" sound. This phase can last 1-6 weeks. Vomiting after coughing fits is common, especially in young children.
The convalescent phase marks the slow resolution of symptoms. Coughing frequency decreases over 2-3 weeks, but residual coughing may continue for up to 10 weeks. Recovery is gradual, and fatigue often persists. Without treatment, the illness can lead to pneumonia, seizures, or brain damage in infants.
| Stage | Duration | Key Symptoms | Contagiousness |
|---|---|---|---|
| Catarrhal | 1-2 weeks | Runny nose, mild fever, dry cough | High (before cough develops) |
| Paroxysmal | 1-6 weeks | Severe coughing fits, "whoop," vomiting | Very high |
| Convalescent | 2-3 weeks (up to 10 weeks) | Gradual reduction in coughing | Low |
Pertussis is frequently mistaken for asthma, bronchitis, or a lingering viral cough. Its early symptoms are indistinguishable from those of other respiratory illnesses. The absence of a "whoop" in many cases-especially in vaccinated individuals or older children-leads to delayed diagnosis. In fact, the CDC reports that about 30% of confirmed pertussis cases in adolescents and adults do not present with the classic whoop.
Another misconception is that pertussis only affects unvaccinated children. While infants under 6 months are at greatest risk, older children and adults can contract and spread the disease. A 2021 study published in Journal of the American Medical Association (JAMA) found that nearly half of pertussis cases in children aged 1-4 years occurred in those who had received at least three doses of the DTaP vaccine, highlighting waning immunity.
Some assume that antibiotics are ineffective once coughing has begun. This is incorrect. Antibiotics such as azithromycin are most effective when started early, ideally within the first 2 weeks of illness. They reduce transmission and shorten symptom duration. However, they do not eliminate coughing in the paroxysmal phase, which is why supportive care remains essential.
In 2022, a kindergarten class in Oregon experienced a pertussis outbreak. The index case was a 5-year-old child who initially presented with a runny nose and mild cough. After 10 days, the child developed severe coughing fits, leading to vomiting and difficulty breathing. Parents reported the child "coughed like he was choking" at night.
By the time the child was diagnosed with pertussis via PCR testing, four classmates had developed similar symptoms. The school closed for five days for contact tracing and antibiotic prophylaxis. All affected children were treated with azithromycin. Two required emergency room visits due to dehydration from post-cough vomiting. The outbreak was contained, but the delay in recognition led to unnecessary exposure.
This case illustrates how early symptoms are dismissed and how quickly pertussis spreads in close environments. It also underscores the importance of considering pertussis in any prolonged cough, even in vaccinated individuals.
Any persistent cough lasting more than 10 days, especially with paroxysms or a whoop, warrants evaluation. In infants, signs of distress-such as apnea (pauses in breathing), cyanosis (bluish skin), or inability to feed-are red flags requiring immediate care. Adults experiencing coughing fits that interfere with sleep or daily activities should also seek assessment.
Testing for pertussis involves a nasopharyngeal swab collected during the catarrhal or early paroxysmal phase. PCR testing is the gold standard. Serology (antibody testing) is used later in the illness when swabs may no longer yield positive results.
Prevention remains the best strategy. The DTaP vaccine is administered at 2, 4, 6, and 15-18 months, with a booster at 4-6 years. Tdap boosters are recommended for adolescents and adults every 10 years. Pregnant women should receive a Tdap dose between 27 and 36 weeks gestation to pass maternal antibodies to newborns.
Understanding the signs of pertussis is critical for timely intervention. Early recognition reduces transmission and prevents severe outcomes, particularly in vulnerable populations. Recognizing the progression from mild cold-like symptoms to violent coughing episodes allows for faster diagnosis and treatment.